The Asia Pacific Tea Tree Oil Market would witness market growth of 7.67% CAGR during the forecast period (2019–2025).
The Asia-Pacific shares immense opportunity for the growth of the global tea tree oil market because of the surge in preference for natural or clean label cosmetic and pharmaceutical products. These products made are purely natural, chemical-free, and has fewer side-effects. Consequently, the Asia- Pacific experiences an increase in the demand for tea tree products. The increasing demand for the tea tree oil is owing to the increased demand for the products that are natural, herbal, and organic and the other factor that is boosting the growth of the market is its increased adoption in the personal care products. Factors affecting the development of the tea tree oil market are the expanding urban population, rise in the disposable income, and the increasing awareness about the benefits of the tea tree oil. The tea tree oil is used in the health care sector for the products that are used for the treatment of cold, fungal infection, skin, dental care, and other medicinal purposes.
Based on Grade, the market is segmented into Pharma & Cosmetic Grade and Therapeutic Grade. Based on Application, the market is segmented into Cosmetics and Toiletries, Therapeutic and Industrial. Based on End User, the market is segmented into FMCG Sector, Cosmetic Sector, Pharmaceutical Sector and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Royal Barenbrug Group, BrettYoung Seeds Limited, Allied Seed, LLC, The Lebermuth Co., Inc., AOS Products Private Limited, Shandong Fuyang Biotech Co. ltd., Integria Healthcare (Australia) Pty Ltd., Young Living Essential Oils LC, Ungerer & Company, Inc., and NOW Foods, Inc.
Scope of the Study
Market Segmentation:
By Grade
• Pharma & Cosmetic Grade
• Therapeutic Grade
By Application
• Cosmetics and Toiletries
• Therapeutic
• Industrial
By End User
• FMCG Sector
• Cosmetic Sector
• Pharmaceutical Sector
• Others
By Country
• China
• Japan
• India
• South Korea
• Singapore
• Australia
• Rest of Asia Pacific
Companies Profiled
• The Royal Barenbrug Group
• BrettYoung Seeds Limited
• Allied Seed, LLC
• The Lebermuth Co., Inc.
• AOS Products Private Limited
• Shandong Fuyang Biotech Co. ltd.
• Integria Healthcare (Australia) Pty Ltd.
• Young Living Essential Oils LC
• Ungerer & Company, Inc.
• NOW Foods, Inc.
Our reports have been used by over 10K customers, including:
275 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
120 pages •
By Infiniti Research Limited
• Feb 2021
Global Carboxymethyl Cellulose Market 2021-2025
The analyst has been monitoring the carboxymethyl cellulose market and it is poised to grow by $ 463.11 mn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on carboxymethyl cellulose market provides a holistic analysis, market size and...
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Active Pharmaceutical Ingredients Market 2021-2025
The analyst has been monitoring the active pharmaceutical ingredients market and it is poised to grow by $ 64.53 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on the active pharmaceutical ingredients market provides a holistic...
The global banana powder market reached a value of US$ 990.6 Million in 2020. Bananas represent the world’s most consumed fresh fruit and the fourth most important food crop in terms of the gross value of production. Unlike raw bananas, banana powder has a shelf-life of almost two years when stored in a cold storage facility in the absence...
Pharmaceutical Analytical Testing Market Report Overview Pharmaceutical Analytical Testing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pharmaceutical Analytical Testing market types and applications. It is a focused study on Pharmaceutical...
The North America medical cyclotron market is expected to reach US$ 109.15 million by 2027 from US$ 80.99 million in 2019; it is estimated to grow at a CAGR of 3.9% from 2020 to 2027. The growth of the market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination toward nuclear scans for accurate...
The Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing includeincreasing focus on pre-clinical development services...
"Selective Estrogen Receptor Degrader (SERDs) Market, Dosage, Price & Clinical Trials Insight 2025" Report Highlights: • Global SERD Market Opportunity: > US$ 2 Billion By 2025 • USA To dominate Global SERD Market • SERD In Clinical Trials: > 15 Drugs • Detailed Clinical insight on All Drugs in clinical...
This This research examines the global analytical X-ray instrumentation market in detail over the 2016 to 2026 period.Analytical X-ray techniques are used for the analysis of materials, including structural and engineering components.
X-ray techniques include X-Ray Diffraction (XRD) and X-Ray Fluorescence (XRF) spectrometry.XRF covers...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the parathyroid hormone market are Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd. and Extend Biosciences, Inc. The global parathyroid hormone market is expected to decline from $1.78 billion in 2019 to $1.70 billion in 2020 at a compound annual growth rate (CAGR) of -4.4%....
Pharmaceutical
Musculoskeletal Disorder
Biosimilar
World
United States
Europe
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.